Financial Disclosure

Stockholm – October 05, 2026 -- Telefonaktiebolaget LM Ericsson repurchased additional Class B shares between September 28 and October 2, 2026, lifting its treasury stock holding to 117,888,663 Class B shares.

Ericsson executes buybacks under a SEK 15 billion repurchase program

The transactions form part of a share buyback program of up to SEK 15,000,000,000 that Ericsson announced on April 16, 2026. The program runs from April 23, 2026, through March 31, 2027, at the latest.

Goldman Sachs handles trades on Nasdaq Stockholm

All acquisitions during the period were carried out on Nasdaq Stockholm by Goldman Sachs Bank Europe SE on Ericsson's behalf. The repurchases were executed under EU Regulation No 596/2014 on market abuse (MAR) and the related Safe Harbour Regulation of March 8, 2016.

Lund, Sweden – October 05, 2026 -- Alfa Laval has initiated full integration of Desmet, the process engineering specialist it acquired in 2022, with completion targeted for July 2027.

Alfa Laval merges Desmet into its Food & Pharma Division after four years as a standalone unit

Desmet, including its RoseDowns and Stolz brands, has operated separately since Alfa Laval's 2022 acquisition. The company will now be absorbed into Alfa Laval's Business Unit Process Engineering Solutions, with the Desmet name retained as a product and process technology brand rather than a standalone entity.

Stockholm – October 05, 2026 -- Skanska has signed a contract worth USD 110 million, about SEK 1.0 billion, with the Renton School District to build a new high school in Renton, Washington, USA. The contract value will be booked into Skanska's US order bookings for the third quarter of 2026.

New campus to house 1,600 students across 32,500 square meters

The three-story, 350,000-square-foot comprehensive high school will provide classroom capacity for 1,600 students. The facility will include core classrooms alongside dedicated spaces for Career and Technical Education, art, science and elective courses.

Auckland – October 05, 2026 -- Aroa Biosurgery Limited (ASX: ARX) reported that its Symphony wound care product achieved a 55% complete closure rate for diabetic foot ulcers within 12 weeks, compared with 35% for standard of care alone, in a peer-reviewed randomized controlled trial published in the International Wound Journal.

Trial enrolled 143 patients across 10 U.S. sites to test Symphony against standard care

The prospective, multicenter RCT randomized patients with Wagner Grade 1 or 2 diabetic foot ulcers to receive either weekly Symphony plus standard of care or standard of care alone, for up to 12 weeks or until complete closure. Ulcers ranged from full-thickness skin wounds to deeper lesions extending into ligaments, tendons, joint capsules or deep fascia.

Tokyo – October 05, 2026 -- Celaid Therapeutics Inc. has completed the second close of its Series B financing round, raising JPY 400 million (approximately USD 2.6 million) with new backing from Shionogi & Co., Ltd. and Teikoku Ventures, Inc.

Shionogi and Teikoku Ventures enter as new strategic investors

The two pharmaceutical-linked investors cited the development progress and therapeutic potential of CLD-001, Celaid's lead hematopoietic stem cell (HSC) therapy candidate, as the basis for their investment. Teikoku Ventures operates as the corporate venture capital arm of the TEIKOKU SEIYAKU Group.

AMED advances Celaid to Stage 3 funding under startup ecosystem program

Celaid also passed the second stage-gate review of AMED's "Strengthening Program for Pharmaceutical Startup Ecosystem,

Melbourne – October 05, 2026 -- CSL and Alentis Therapeutics have signed an exclusive global collaboration to develop and commercialize lixudebart, a potential first-in-class therapy targeting claudin-1 for rare kidney and liver diseases, with CSL paying Alentis US$355 million upfront and up to US$1.2 billion in commercial milestones.

CSL pays $355 million upfront, commits $1.2 billion in milestone payments

Under the agreement, CSL will fully fund the ongoing Phase 2 RENAL trial, the planned Phase 3 trial in ANCA-associated vasculitis with rapidly progressive glomerulonephritis (AAV-RPGN), and Phase 2 trials in focal segmental glomerulosclerosis (FSGS) and primary sclerosing cholangitis (PSC). Once commercialized, global profits will be split 55 percent to CSL and 45 percent to Alentis.

São Paulo – – October 03, 2026 -- Brazilian sanitation group Aegea Saneamento e Participações S.A. has raised R$1.5 billion in new financing since the end of the second quarter of 2026, pushing its total disbursed funding for the year to R$6 billion.

Aegea closes three debt transactions backing regional water utilities

The company secured R$700 million in 'Ecoinvest' debentures for subsidiary Companhia Riograndense de Saneamento (CORSAN), arranged with Banco Bradesco BBI S.A. and carrying a 10-year maturity. A further R$420 million came from a three-year extension of a debenture issuance tied to Águas de Governador Valadares SPE S.A., executed with XP Investimentos. A third transaction, worth R$330 million, extended by three years a debenture issuance for Ambiental Metrosul Concessionária de Saneamento SPE S.A., arranged with Banco do Estado do Rio Grande do Sul (Banrisul).

Indianapolis – October 03, 2026 -- Allison Transmission Holdings, Inc. (NYSE: ALSN) completed a partial redemption of $100 million aggregate principal amount of its 4.750% Senior Notes due 2027 on October 03, 2026.

Allison exercises optional redemption right under 2017 indenture

The redemption was carried out pursuant to Allison's optional redemption right under the indenture governing the notes, dated October 03, 2026. Notes were redeemed at a price of 100.00% of principal amount plus accrued and unpaid interest up to, but not including, the redemption date.

$300 million of notes remain outstanding after paydown

Following completion of the partial redemption, $300 million aggregate principal amount of the 4.750% Senior Notes due 2027 remain outstanding. The move reduces Allison's near-term debt load tied to the 2027 maturity.

Destin, Fla. – October 03, 2026 -- Awayday, a national vacation rental management company, has closed a strategic investment from Warburg Pincus through its Capital Solutions Founders Fund, with terms of the deal undisclosed.

Ares and LightBay Capital retain control despite new capital infusion

An Ares Private Equity fund and LightBay Capital, Awayday's existing majority owners, will remain the controlling shareholders following the transaction. Awayday currently manages more than 18,000 properties across the United States through a portfolio of local brands, backed by a workforce exceeding 1,800 employees.

San Francisco – October 03, 2026 -- Airbnb, Inc. (NASDAQ: ABNB) will release its third-quarter 2026 financial results after market close on October 03, 2026.

Airbnb schedules investor webcast for November 5 at 2:00 p.m. PT

The company will host an audio webcast the same day at 2:00 p.m. PT / 5:00 p.m. ET to discuss the quarterly results. The shareholder letter and webcast link will be published on Airbnb's Investor Relations website. Interested parties can register in advance for the call, with instructions provided upon registration.